Bicara Therapeutics BCAX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $323.46M+235% | $96.69M-43.7% | $171.67M-60.7% | $436.61M-5.5% | $462.07M-5.6% | ||
| $216.29M-32.0% | $318.12M+168% | $118.49M— | —— | —— | ||
| $544.92M+29.1% | $422.05M+41.9% | $297.37M-33.1% | $444.39M-5.6% | $470.75M-6.3% | ||
| $346K+4.8% | $330K+144% | $135K+15.4% | $117K-14.0% | $136K-12.3% | ||
| $553.6M+28.4% | $430.99M+1.5% | $424.69M-6.4% | $453.59M-5.1% | $478.08M-6.3% | ||
| $39.34M+35.9% | $28.95M+37.7% | $21.03M+22.1% | $17.23M-9.9% | $19.12M+6.3% | ||
| $39.64M+34.2% | $29.54M+34.8% | $21.91M+19.1% | $18.39M-3.8% | $19.12M+5.5% | ||
| 500M0.0% | 500M0.0% | 500M0.0% | 500M0.0% | 500M+7,142,757% | ||
| -$415.18M-15.7% | -$358.97M-11.6% | -$321.58M-12.7% | -$285.25M-10.6% | -$257.86M-16.7% | ||
| $513.96M+28.0% | $401.45M-0.3% | $402.78M-7.4% | $435.2M-5.2% | $458.96M-6.7% | ||
| $553.6M+28.4% | $430.99M+1.5% | $424.69M-6.4% | $453.59M-5.1% | $478.08M-6.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Bicara Therapeutics's total assets?
- Bicara Therapeutics (BCAX) holds $553.6M in total assets, up 15.8% year over year.
- How much debt does Bicara Therapeutics have?
- Bicara Therapeutics carries $1.4M in total debt against $514.0M of shareholders' equity, a debt-to-equity ratio of 0.00.
- How much cash does Bicara Therapeutics have?
- Bicara Therapeutics holds $323.5M in cash and equivalents.
- Can Bicara Therapeutics cover its short-term obligations?
- Its current ratio is 13.85 — current assets exceed current liabilities.
- Where does Bicara Therapeutics's balance sheet data come from?
- Every line is extracted from Bicara Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.